AI for Mental Health Prescription Refills: New Utah Pilot Program

Utah has become the first state in the United States to permit the use of artificial intelligence to handle prescription refills, marking a significant shift in the intersection of healthcare, and technology. The initiative, coordinated through the state’s Office of Artificial Intelligence Policy, aims to automate routine administrative tasks to reduce the workload on clinicians and lower costs for patients.

The state’s broader efforts began with a partnership with Doctronic, an AI-native health platform, for a yearlong pilot program that launched in December 2025. This program allows residents to renew medications online through a commercial AI platform without the requirement of speaking with a doctor’s office first.

Mechanics of the AI Refill System

The Doctronic system is designed to process 30-, 60-, or 90-day refills for 190 commonly prescribed medications. To ensure security and prevent misuse, the platform requires Utah residents to confirm their residency and provide photo identification and selfies during the renewal process.

Once identity is verified, a chatbot interacts with the patient to gather information regarding their pharmacy, current symptoms, other medications being taken, and any updates to their medical history. If the AI approves the renewal, the prescription is sent directly to the pharmacy for a fee of $4 per renewal. If the system determines a prescription is ineligible for a refill, it provides the patient with a code for a free video consultation with a physician.

To maintain safety standards, the pilot program operates under a regulatory mitigation agreement with strict parameters. The AI is prohibited from issuing new prescriptions, managing treatment plans, or handling injectables, painkillers, and drugs used for attention-deficit/hyperactivity disorder (ADHD).

Focus on Psychiatric Medication

A specific application of this technology is being implemented by Legion Health, which focuses on the renewal of certain psychiatric medications. This service targets lower-risk antidepressants, including Zoloft, Wellbutrin, and Prozac, and is expected to cost patients approximately $19 per month.

Eligibility for the psychiatric AI refill service is limited to patients who are considered stable on their current medication. Those who have experienced recent psychiatric hospitalizations or recent changes in medication dosage are disqualified from using the system. Patients must check in with a licensed healthcare provider after a specific number of refills or within a designated timeframe.

The Legion Health chatbot is programmed to screen for warning signs, such as suicidal thoughts, as well as side effects and general symptoms. Any response that raises a safety concern triggers an automatic escalation, sending the case to a human doctor for review before any refill is approved.

Industry Debate and Safety Concerns

Despite the implemented guardrails, the transition to AI-managed refills has sparked debate among medical professionals. Brent Kious, a psychiatrist and professor at the University of Utah School of Medicine, has questioned whether the benefits of such systems are overstated.

Kious has raised concerns regarding the reliance on self-reported data, noting that patients may not always recognize their own side effects or may provide inaccurate answers to the chatbot to ensure they receive their medication. He has further argued that psychiatric care often relies on nuanced observations—such as subtle changes in sleep, mood, or behavior—that a series of binary questions cannot capture.

Kious has pointed to a lack of transparency in the operation of these AI tools, suggesting that this opacity makes it difficult for both physicians and patients to fully trust the software’s decisions.

Balancing Access and Quality of Care

Supporters of the program argue that the technology is a necessary response to severe shortages of mental health providers in Utah. In some regions, patients face wait times of several weeks to see a provider. By delegating routine, guideline-based renewals to AI, the state hopes to free up clinicians to focus on patients with more complex needs.

The Utah Office of Artificial Intelligence Policy has structured the rollout in a three-phased comprehensive review process. This includes extensive identity and prescription verification protocols and patient privacy measures to prevent incidental disclosures. Licensed professionals continue to oversee the implementation of these tools to ensure they meet established safety and quality standards.

As Utah continues to experiment with AI in various sectors of healthcare, companies like Legion Health have indicated plans to expand their services beyond a single state. The current pilot serves as a test case for whether the convenience of software-driven transactions can be balanced with the personal nature of medical care.